Therabron Therapeutics to Present at Upcoming Industry and Investor Conferences

ROCKVILLE, Md., June 1, 2016 /PRNewswire/ -- Therabron Therapeutics, Inc., a clinical-stage biotechnology company dedicated to advancing a new standard in respiratory care, today announced that President and Chief Executive Officer, Thomas F. Miller, PhD, MBA, will be presenting a corporate overview and update at two, key, upcoming conferences: the BIO International Convention, taking place June 6-9, 2016 at the Moscone Center in San Francisco, CA; and the Jefferies 2016 Healthcare Conference, taking place June 7-10, 2016 in New York City.

Details are as follows:

About Therabron Therapeutics, Inc.

At Therabron Therapeutics, we are advancing a platform of novel therapeutic proteins in an effort to change how a variety of neglected and under-treated respiratory and fibrotic conditions are managed. We are a privately held, clinical-stage biopharmaceutical company, developing a new class of drugs based on the naturally occurring secretoglobin family of proteins, which includes the CC10 protein — a molecule with both anti-inflammatory and immunomodulatory mechanisms. Therabron's product candidates have the potential to become first-in-class biologic therapeutics. For additional information, please visit www.therabron.com.

SOURCE Therabron Therapeutics, Inc.

Related Links

http://www.therabron.com